文献速递泌尿与男性生殖病理细胞病理与分子病理

延胡索酸水合酶缺陷型肾细胞癌的细胞学诊断:单中心经验

Cytologic diagnosis of fumarate hydratase-deficient renal cell carcinoma: A single-institutional experience.
PubMed 文献 · Cancer Cytopathol · 2025-01-01

本研究回顾了5例经FNA细胞学诊断的延胡索酸水合酶缺陷型肾细胞癌(FHRCC),其中2例为前瞻性识别。所有病例均见核周晕等特征性细胞形态,免疫组化推荐FH与2-琥珀半胱氨酸双标志物组合用于确诊。

要点

  • FHRCC细胞学可见核周晕、大核仁及胞质空泡等特征
  • 5例中FH免疫组化明确缺失3例(60%),2-琥珀半胱氨酸均阳性(100%)
  • 推荐FH与2-琥珀半胱氨酸双标志物组合确诊

核心结论

  • FHRCC的细胞学标本具有可支持初步诊断的显著细胞形态学特征。
  • 推荐在有限活检样本中使用FH与2-琥珀半胱氨酸双标志物组合免疫组化确诊。

研究设计与样本

  • 单中心回顾性细胞学FNA病例分析,共5例FHRCC,其中2例为前瞻性识别。
  • 样本包括4例FNA联合粗针活检和1例FNA联合细胞块;活检部位为肾、胸壁、大网膜、肺和颈部淋巴结各1例。

主要发现

  • 所有病例均见恶性上皮细胞,伴核增大、核膜不规则、核仁显著及中等至丰富胞质。
  • 所有病例均见核周晕,表现为染色质边集及大核仁周围淡染区。
  • 新描述的细胞学特征包括胞质大空泡、嗜酸性小球、细胞吞噬现象及花卉样细胞群。
  • 涂片少见乳头状结构,细胞块切片显示不同组织结构模式。

关键数值与推荐

  • FH免疫组化明确缺失3/5例(60%)。
  • 2-琥珀半胱氨酸免疫组化阳性5/5例(100%)。

临床怎么用

  • 细胞学标本见到核周晕等特征时应注意提示FHRCC可能。
  • 对有限活检样本采用FH与2-琥珀半胱氨酸双标志物组合免疫组化确诊。

局限性

  • 单中心5例的小样本回顾性分析,2例为前瞻性识别。
  • 原文未报告诊断敏感性、特异性等统计指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fumarate hydratase-deficient renal cell carcinoma (FHRCC) is an aggressive carcinoma that typically presents as advanced-stage disease. Prompt recognition of FHRCC is critical for appropriate clinical care and genetic counseling for patients and family members. However, diagnosing FHRCC from cytology specimens is challenging, with limited characterization and no reports describing prospectively identified cases. METHODS: Cytology fine-needle aspiration (FNA) cases diagnosed as FHRCC were reviewed, including two prospectively identified cases. RESULTS: Five cases of FHRCC diagnosed by FNA cytology were identified in five unique patients. The cytologic samples included four FNAs with core biopsy and one FNA with cell block. Biopsy sites included kidney (n = 1), chest wall (n = 1), omentum (n = 1), lung (n = 1), and cervical lymph node (n = 1). All cases demonstrated cytologically malignant epithelial cells characterized by enlarged, round nuclei with variable pleomorphism, irregular nuclear membranes, prominent nucleoli, and moderate-to-abundant amounts of cytoplasm. Perinucleolar halos characterized by chromatin margination and pallor around macronucleoli were seen in all cases. Cytologic features not previously described included cytoplasmic macrovacuoles and eosinophilic globules, cytophagocytosis, and floral groups. Papillary architecture was rarely present on aspirate smears. Cell block sections showed variable architectural patterns. By immunohistochemistry, FH was definitively lost in three of five cases (60%), and 2-succinocysteine was positive in all 5 cases (100%). CONCLUSIONS: Cytologic specimens of FHRCC demonstrate salient cytomorphologic features that can support their initial diagnosis. Confirmatory immunohistochemical testing using a dual panel of fumarate hydratase and 2-succinocysteine is recommended for the diagnosis in limited biopsy samples.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Mullane PC, Qian X, Lau HD, et al. Cytologic diagnosis of fumarate hydratase-deficient renal cell carcinoma: A single-institutional experience. Cancer Cytopathol. 2025. PMID: 39804329. doi:10.1002/cncy.22931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。